Although much evidence has been gathered demonstrating that. immune effectors can play a significant role in controlling tumor growth under natural conditions or in response to therapeutic manipulation, it is clear that malignant cells do evade immune surveillance in most cases. Considering that anticancer active specific immunotherapy seems to have reached a plateau Of results and that currently no vaccination regimen is indicated a,,, a standard anticancer therapy, the dissection of the molecular events underlying tumor immune escape is the necessary condition to make anticancer vaccines a therapeutic weapon effective enough to be implemented ill the routine clinical setting. Recent years have witnessed significant advances in our understanding of the molecular mechanisms underlying tumor immune escape. These mechanistic insights are fostering the development of rationally designed therapeutics aimed to revert the immunosuppressive Circuits that undermine an effective antitumor immune response. In this review, the best characterized mechanisms that allow cancer cells to evade immune surveillance are overviewed and the most debated controversies constellating this complex field are highlighted.
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Bingle, L
Brown, NJ
论文数: 0引用数: 0
h-index: 0
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Brown, NJ
Lewis, CE
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, EnglandUniv Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Bingle, L
Brown, NJ
论文数: 0引用数: 0
h-index: 0
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Brown, NJ
Lewis, CE
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, EnglandUniv Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England